Showing results (131-140 of 345) with videos related to

Sort By:
Pageof 35
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 26, 2008
Are all low molecular weight heparins equivalent in the management of venous thromboembolism?Jawed Fareed, Walter Jeske, Daniel Fareed, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|August 30, 2011
Upregulation of inflammatory mediators in end-stage renal disease as measured using biochip array technologyRachael Davis, Vinod Bansal, Evangelos Litinas, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 14, 2019
Matrix Metalloproteinases and Their Inhibitors and Proteoglycan 4 in Patients Undergoing Total Joint ArthroplastyChase Thorson, Kevin Galicia, Andrew Burleson, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 9, 2020
Studies on Tissue Factor Pathway Inhibitor Antigen Release by Bovine, Ovine and Porcine Heparins Following Intravenous Administration to Non-Human PrimatesAhmed Kouta, Debra Hoppensteadt, Emily Bontekoe, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 21, 2012
Cross-reactivity of various thrombin products with anti-rabbit antibodies to bovine, human, and recombinant thrombinNasir Sadeghi, He Zhu, Saayi Krushna Gadham Setty, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 23, 2011
Upregulation of microparticles in DIC and its impact on inflammatory processesSaudur Rahman, Mark Cichon, Debra Hoppensteadt, et al.
Seminars in Thrombosis and Hemostasis|February 14, 2009
Pregnancy outcome in women with antiphospholipid antibodies: report on a retrospective studyLothar Heilmann, Martin Schorch, Thomas Hahn, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 26, 2004
Acute myocardial infarction in a patient with essential thrombocythemia treated with glycoprotein IIb/IIIa inhibitorCetin Gül, Turhan Kürüm, Muzaffer Demir, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|August 25, 2016
Recombinant Factor VIIa-Mediated Activation of Prothrombin Complex ConcentratesNasiredin Sadeghi, Massimo Iacobelli, Behroz Vaziri, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 17, 2023
The Relevance of Thrombo-Inflammatory Biomarkers and Their Relationship with Circulating Glycosaminoglycans in End-Stage Renal Disease PatientsMadeline Allen, Vinod Bansal, Fakiha Siddiqui, et al.
Pageof 35